HI
Vyome Holdings, Inc. (HIND)
NASDAQ·Healthcare·Biotechnology
$2.18
+0.69%
Mkt Cap $15.01M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$15.00
Range $15.00 – $15.00
Implied Upside
+588.1%
Consensus $15.00 vs current $2.18
NASDAQ·Healthcare·Biotechnology
$2.18
+0.69%
Mkt Cap $15.01M
No recent rating data.
Price Target (1 analysts)
$15.00
Range $15.00 – $15.00
+588.1%
Consensus $15.00 vs current $2.18